ATH 33.3% 0.4¢ alterity therapeutics limited

He traderlilly - has somebody hacked your account? It made more...

  1. 332 Posts.
    lightbulb Created with Sketch. 17
    He traderlilly - has somebody hacked your account? It made more sense than usual and demonstrated thought and/or research!

    PBT is measuring a combination of biomarkers, of which amyloid burden is just one. PBT has leveraged the AIBL study data and methodologies.

    From http://aibl.csiro.au/research/neuroimaging/ ...

    "The AIBL study is the largest study in the world involving Positron Emission Tomography (PET) scans using Pittsburgh Compound-B (PIB), a PET amyloid-imaging agent.

    PIB is a radioactive marker used for in vivo imaging of Aß deposits using PET and is derived from Thioflavin T, a dye used to stain Aß plaques in histology.

    PIB has several properties that make it attractive for PET imaging: it bounds to insoluble species of Amyloid with high affinity, it crosses the blood-brain barrier and enters brain in sufficient amount to be imaged using PET, and it clears rapidly from normal tissues as shown by several animal and human studies.

    287 AIBL study participants have been imaged using Magnetic Resonance Imaging and PET.

    In addition to PET-PIB, participants are undergoing several scans, including PET-FDG, to assess brain function, and a series of Magnetic Resonance Imaging contrasts for anatomical characterisation (T1W, PDW, T2W), structural integrity of the white matter (DWI), and pathological imaging (FLAIR, SWI).

    MRI is a powerful method to image with exquisite anatomical details the different tissues of the brain. It has become an essential tool to assess Alzheimer’s because of the cortical atrophy associated with neuro-degenerescence, which can be measured by MRI. In particular, relatively fast T1W acquisitions offer very good contrast between white and gray matters allowing the precise delineation of the outer cortical mantel. Using algorithms developed at the CSIRO Australian e-Health Research Centre, fast and accurate automatic segmentation of the brain into its main tissue types and estimates of the thickness of the gray matter can be achieved in 3D."

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $1.447K 368K

Buyers (Bids)

No. Vol. Price($)
40 52624257 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 127090587 26
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.